CD43 (Ly-48) MicroBeads, mouse

CD43 (Ly-48) MicroBeads were developed for the isolation of untouched resting B cells (B-2 cells) from peripheral lymphoid tissues or late B cell progenitors from bone marrow.

qualityAssuranceSatisfaction
guaranteed
more »
Choose your product:

Related products for CD43 (Ly-48) MicroBeads, mouse

Specifications for CD43 (Ly-48) MicroBeads, mouse
Overview

CD43 (Ly-48) MicroBeads were developed for the isolation of untouched resting B cells (B-2 cells) from peripheral lymphoid tissues or late B cell progenitors from bone marrow.

Detailed product information
Background information

The CD43 antigen is expressed on nearly all leukocytes except immature and mature resting B cells.

Detailed separation procedure

By using CD43 MicroBeads, all CD43-expressing cells are magnetically labeled, whereas the resting B cell subset stays untouched and is collected in the column effluent.

Downstream applications

Resting B cells isolated with CD43 MicroBeads have been used for various studies on B cell differentiation and related molecular processes. Resting B cells isolated from spleen were used for in vitro analyses on antibody class switching.1 They were separated for comparative analysis on B cell receptor signal transduction in wild type and immunodeficient mice2 or were used as starting material for studies on germinal center formation.3

Columns

For positive selection: MS, LS, XS, or autoMACS® Columns. For depletion: LD, D, or autoMACS Columns.

Product data and images for CD43 (Ly-48) MicroBeads, mouse
Figure 1

Isolation of untouched B cells from a mouse spleen cell suspension using CD43 MicroBeads, a MiniMACS™ Separator, and an MS Column.

Resources for CD43 (Ly-48) MicroBeads, mouse
Citations for CD43 (Ly-48) MicroBeads, mouse
Publications
  1. Xu, S. et al. (2000) B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice. Int. Immunol. 12: 397-404
  2. de Vinuesa, C. G. et al. (2000) Germinal centers without T cells. J. Exp. Med. 191: 485-493
  3. Hein, K. et al. (1998) Processing of switch transcripts is required for targeting of antibody class switch recombination. J. Exp. Med. 188: 2369-2374

You have previously chosen International as your location.
What do you want to do?